Development Strategy

Safety, Efficacy, Cost: The Trifecta for Increasing Access to CAR-T Therapies

With hundreds of companies and clinical trials investigating CAR T-cell therapies, there exist opportunities to expand the applications of—and broaden access to—these novel therapeutics to address unmet medical needs. Fundamental to these efforts to make CAR T-cell therapies more broadly available is the need to improve the safety, efficacy, and cost of these treatments.

In this white paper, we explore the history and current landscape of CAR T-cell therapy research and development, highlighting strategies that are being investigated to increase safety and efficacy, while also lowering cost.

To read more, download the complete white paper.